Institutional Holdings in Merck & Co. Decline by Over 20% in Q1 2026

A review of the most recent 13F filings indicates a bearish shift among a segment of institutional investors regarding Merck & Co Inc (MRK). The data, covering the reporting period ending March 31, 2026, highlights a trend of position reduction among hedge fund managers. While 13F filings provide a window into institutional sentiment, they only disclose long positions. This limitation means the data may not reflect the full scope of a fund's strategy, as short positions and hedging activities are not required to be disclosed to the SEC. In terms of concrete figures, the aggregate share count among funds holding MRK dropped from 44,033,654 shares at the end of 2025 to 34,977,565 shares by the end of March 2026. This represents a total decline of approximately 20.57%, or a reduction of 9,056,089 shares. Within a specific sample of 53 recent filers, 29 funds held the stock. Among these, 12 funds decreased their existing positions, while 8 increased their holdings and 5 established new positions. This divergence suggests mixed sentiment among individual managers, though the aggregate trend remains negative. Institutional ownership trends often serve as a signal for retail and professional traders to conduct deeper fundamental research. The significant reduction in aggregate shares suggests a cooling of conviction among a portion of the hedge fund community for the first quarter of the year.